Publicador de contenidos

Back to 20211117_CIE_curiel_alvaro

The biochemist Álvaro Curiel is the best postdoctoral scientist at Columbia University.

Former student of the University of Navarra receives this recognition for his research in advanced personalised therapies for pancreatic cancer.

/Álvaro Curiel

17 | 11 | 2021

Biochemist Álvaro Curiel García (Palencia, 33 years old) has received recognition from Columbia University (United States) for the research carried out in pancreatic cancer in 2020 and for his partnership as a scientist during the COVID19 pandemic.

This award is part of the National Postdoctoral Appreciation Week and is awarded by each member university of the association American Postdoctoral Scientists. In Dr. Curiel's case, he received it from Columbia University, where he is a visiting scholar, from among more than 1,500 postdoctoral researchers.

Álvaro Curiel had to stop his research because of the health status and take care, together with other colleagues from laboratory, of the collection and analysis of samples from critical COVID patients. "From laboratory and with financial aid of many volunteers, we set up a platform that helped at different levels: research-PCR, sterilisation of masks and financial aid psychological" says researcher.

Dr Curiel has now resumed his research in personalised therapy in pancreatic cancer at Columbia University. "We take biopsies from patients and using the latest sequencing tools and artificial intelligence, we look for the best treatment for the patient. Once we have it, we test these candidate treatments in mice and if the treatment is successful, we start the clinical essay in the patient," he adds.

Complementary to this main line of research, Álvaro Curiel also develops software tools to help research programs of study carried out in other laboratories "without the need for complex genomic analysis or advanced programming knowledge".

Álvaro Curiel García is former student of Biology and Biochemistry of the School of Sciences of the University of Navarra (2012) and PhD in Molecular Biosciences by the Centro Nacional de Investigaciones Oncológicas (2019). He is currently a postdoctoral fellow at the Columbia University Cancer Center (New York, USA).

"For me it is very special and emotional to receive this award considering everything that has happened in the last year and a half. Since the beginning of the pandemic, where we had to stop experiments and treatments, I was very clear that I wanted to help in whatever way was necessary and to contribute," says researcher.